Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

Autor: Pinto, C. *, Di Fabio, F., Siena, S., Cascinu, S., Rojas Llimpe, F.L., Ceccarelli, C., Mutri, V., Giannetta, L., Giaquinta, S., Funaioli, C., Berardi, R., Longobardi, C., Piana, E., Martoni, A.A.
Zdroj: In Annals of Oncology March 2007 18(3):510-517
Databáze: ScienceDirect